Optimized Ginkgo biloba extract EGb 761®: boosted therapeutic benefits with minimized CYP enzyme interference
Journal of Pharmacy & Pharmaceutical Sciences · 2025
DOI: 10.3389/jpps.2025.14614 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy & Pharmaceutical Sciences, 2025. Verfasst von Sunbeom Kwon und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Convergent Biotechnology and Advanced Materials Science, College of Life Sciences, Kyung Hee University, Yongin, Republic of Korea. Hauptthemen laut MEDLINE: Ginkgo biloba, Plant Extracts, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Enzyme System. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Object The development of cognitive-enhancing drugs from Ginkgo biloba extract is actively pursued worldwide. This study compares the chemical compositions of different G. biloba extracts and their formulated drugs, highlighting the distinguishing characteristics and potential benefits of optimized G. biloba extract, EGb 761 ® .
Methods
We analyzed three G. biloba extracts and fifteen formulated drugs using HPLC, principal component analysis, and LC-MS/MS to identify key compositional differences. Molecular docking analysis was conducted to evaluate the binding affinity of the key component with a target protein involved in cognitive enhancement. CYP inhibition assays were performed on selected extracts and their derived products to examine drug-drug interactions.
Results
EGb 761 ® and its formulated drugs displayed a unique composition, characterized by a significantly higher level of protocatechuic acid (PCA). PCA demonstrated strong interactions with the M 1 receptor, acetylcholinesterase, glycogen synthase kinase-3, which are the key targets for cognitive enhancement. CYP inhibition assays indicated that EGb 761 ® and the drugs derived from EGb 761 ® had lower inhibitory activity compared to other samples.
Conclusion
The high PCA content in EGb 761 ® may contribute to cognitive benefits. With low CYP inhibition, it suggests minimal interference with drug metabolism, highlighting its potential as a safer cognitive enhancer. Ultimately, this study indicates that the composition of EGb 761 ® can be effectively leveraged for its pharmacological benefits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Convergent Biotechnology and Advanced Materials Science, College of Life Sciences, Kyung Hee University, Yongin, Republic of Korea.
- BK21 Interdisciplinary Program in IT-Bio Convergence System, Kyung Hee University, Yongin, Republic of Korea.
Zitieren
APA
Kwon, S., Jeong, S., & Lee, S. (2025). Optimized Ginkgo biloba extract EGb 761®: boosted therapeutic benefits with minimized CYP enzyme interference. Journal of Pharmacy & Pharmaceutical Sciences. https://doi.org/10.3389/jpps.2025.14614
Vancouver
Kwon S, Jeong S, Lee S. Optimized Ginkgo biloba extract EGb 761®: boosted therapeutic benefits with minimized CYP enzyme interference. Journal of Pharmacy & Pharmaceutical Sciences. 2025. doi:10.3389/jpps.2025.14614
BibTeX
@article{Kwon2025,
author = {Kwon, Sunbeom and Jeong, Suji and Lee, Seulah},
title = {Optimized Ginkgo biloba extract EGb 761®: boosted therapeutic benefits with minimized CYP enzyme interference},
journal = {Journal of Pharmacy & Pharmaceutical Sciences},
year = {2025},
doi = {10.3389/jpps.2025.14614}
}
EUVIMED